Abbott Stock Slips After Company Ordered to Pay $495 Million in Baby Formula Case

Trending 2 months ago

Key Takeaways

  • A assemblage successful St. Louis ruled connected Friday that Abbott Laboratories must salary $495 cardinal successful compensation and damages successful a suit involving nan company's premature babe formula.
  • Abbott was sued by an Illinois female whose girl contracted necrotizing enterocolitis aft being fixed nan look successful nan hospital.
  • The institution has denied its merchandise is unsafe.
  • Abbott shares fell arsenic overmuch arsenic 5% successful early trading Monday.

Shares of Abbott Laboratories (ABT) came nether unit Monday aft a assemblage successful St. Louis precocious Friday ordered nan institution to salary $495 cardinal successful compensation and damages successful a suit complete nan company’s specialized look for premature babies.

Illinois resident Margo Gill brought nan lawsuit against Abbott, claiming that nan patient grounded to pass that nan Similac Special Care 24 High Protein marque fixed to her girl successful nan infirmary could origin necrotizing enterocolitis, a perchance deadly illness of nan bowels. The woman contracted nan illness, and while she survived, she suffers from neurological harm that requires semipermanent care. The verdict calls for Abbott to salary $95 cardinal successful compensatory damages, and $400 cardinal successful punitive damages. 

Abbott has denied its look is dangerous, pinch CEO Robert Ford saying successful nan company’s first 4th net telephone that “there are objective studies that person many times established that these products are safe.”

Investopedia reached retired to some Abbott and nan rule patient of TorHoerman Law, which represented Gill, but neither responded. 

The institution and Britain’s Reckitt Benckiser, shaper of Enfamil, are facing hundreds of lawsuits relating to their babe formula.

Abbott shares were down 1.3% successful caller trading, aft falling arsenic overmuch arsenic 5% successful early trading.

TradingView

More
Source investopedia
investopedia